Sector
PharmaceuticalsOpen
₹150.45Prev. Close
₹148.81Turnover(Lac.)
₹2,318.38Day's High
₹159.25Day's Low
₹148.3252 Week's High
₹185.552 Week's Low
₹101.01Book Value
₹100.36Face Value
₹1Mkt Cap (₹ Cr.)
1,661.48P/E
24.1EPS
6.55Divi. Yield
0.32Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 10.51 | 10.42 | 10.37 | 10.31 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 977.94 | 926.58 | 841.06 | 745.33 |
Net Worth | 988.45 | 937 | 851.43 | 755.64 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 |
---|---|---|---|---|
Revenue | 636.35 | 465.51 | 441.95 | 426.59 |
yoy growth (%) | 36.7 | 5.33 | 3.6 | 43.2 |
Raw materials | -343.94 | -253.3 | -236.72 | -225.14 |
As % of sales | 54.04 | 54.41 | 53.56 | 52.77 |
Employee costs | -65.05 | -58.6 | -44.02 | -33.84 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 |
---|---|---|---|---|
Profit before tax | 123.65 | 91.18 | 121.71 | 120.01 |
Depreciation | -13.84 | -13.76 | -8.83 | -5.74 |
Tax paid | -33.73 | -23.68 | -29.37 | -45.57 |
Working capital | 74.06 | 16.34 | 44.64 | -0.64 |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 36.7 | 5.33 | 3.6 | 43.2 |
Op profit growth | 19.39 | -8.69 | 7.58 | 5.23 |
EBIT growth | 34.17 | -24.46 | 2.52 | 31.32 |
Net profit growth | 37.27 | -26.89 | 24.04 | 30.55 |
Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|---|
Gross Sales | 809.73 | 770.24 | 751.59 | 747.45 | 577.21 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 809.73 | 770.24 | 751.59 | 747.45 | 577.21 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 36.49 | 28.74 | 17.79 | 31.49 | 20.22 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Whole-time Director
Vibha G Sharma
Whole-time Director
Shruti Vishal Rao
Non-Exec. & Independent Dir.
Santosh Parab
Company Sec. & Compli. Officer
Aditi Bhatt
Non-Exec. & Independent Dir.
Shilpa Bhatia
Managing Director
Gagan Harsh Sharmma
Chairman
Nandkumar Kashinath Chodankar
102 Hyde Park Sakivihar Road,
Andheri East,
Maharashtra - 400072
Tel: 91-22-42160000
Website: http://www.blissgvs.com
Email: cs@blissgvs.com; info@blissgvs.com
21 Shakil Niwas,
Mahakali Caves Road, Andheri (E),
Mumbai - 400 093
Tel: 91-22-28262920
Website: www.unisec.in
Email: info@unisec.in
Summary
Bliss GVS Pharma Limited was originally incorporated as a Private Limited Company in the name of Bliss Chemicals & Pharmaceuticals India Private Limited in 1984. The status converted into a Public Lim...
Read More
Reports by Bliss GVS Pharma Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.